EP0031/A400 is being developed jointly by Ellipses in a global clinical phase 1/2 trial under the name EP0031 (NCT05443126) and Kelun Biotech (6990.HK) in China under the name A400 (NCT05265091).

In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

European stocks opened lower, mirroring last week's decline, with travel and media sectors lagging. Novo Nordisk rebounded ...

The battles over abortion in the U.S. are increasingly focusing on the pills that are now the most common way pregnancies are ...

There were no roll call votes in the House or Senate last week. Both branches spent most of their time in session listening ...

A popular brand of nitrous oxide sold in smoke shops and at retailers across South Florida is dangerous and addictive and ...

Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

If you have nocturnal (nighttime) leg cramps, your doctor might prescribe quinine (Qualaquin)-even though the U.S. Food and Drug Administration has approved it for only one purpose: to treat malaria ...

The bird flu outbreak has taken concerning turns, with more than 60 human cases confirmed. Experts outlined four signs that ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The Food and Drug Administration recalled more than two million cans of Jarritos coconut water. The recall affects nearly 170 ...